Publication:
Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia

dc.contributor.buuauthorGümüş, Ertaç
dc.contributor.buuauthorAtalay, Mehmet Aral
dc.contributor.buuauthorDemir, Bilge Çetinkaya
dc.contributor.buuauthorGüneş, Esra Şahin
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentKadın Hastalıkları ve Doğum Ana Bilim Dalı
dc.contributor.researcheridAAH-9834-2021
dc.contributor.scopusid57185356600
dc.contributor.scopusid53863297800
dc.contributor.scopusid36923039100
dc.contributor.scopusid57185668300
dc.date.accessioned2022-12-08T08:36:49Z
dc.date.available2022-12-08T08:36:49Z
dc.date.issued2016-01-29
dc.description.abstractObjective: The objective of this study is to investigate maternal serum and neonatal umbilical cord asymmetric dimethylarginine (ADMA) levels in prediction of perinatal prognosis in pregnancies with preeclampsia (PE) and fetal intrauterine growth retardation (IUGR) accompanying PE (PE+IUGR).Methods: Maternal serum ADMA (msADMA) and neonatal umbilical cord ADMA (ucADMA) levels were studied from 34 patients with PE, 25 patients with PE+IUGR, and 30 healthy pregnant controls in this prospective case-control study. Umbilical artery Doppler indices of fetuses, birth weights, Apgar scores, umbilical artery pH measurements of neonates, and admissions to neonatal intensive care unit (NICU) were recorded.Results: Median msADMA was significantly higher in PE and PE+IUGR groups (p=0.024 and p=0.011, respectively), and ucADMA was significantly higher in PE and PE+IUGR groups than the control group (p=0.029 and p=0.018, respectively). Median msADMA and ucADMA levels were significantly higher in the PE+IUGR group than the PE group (p=0.019 and 0.021, respectively). ucADMA levels did not correlate with fetal umbilical arterial blood flow neither in the PE nor in the PE+IUGR group (p=0.518 and p=0.892, respectively). None was related with neonatal umbilical artery pH or NICU admission rates.Conclusions: msADMA and ucADMA correlated with severity of PE. msADMA and ucADMA failed to predict perinatal outcome in patients with PE and PE+IUGR.
dc.identifier.citationGümüş, E. vd. (2016). "Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia". Journal of Maternal-Fetal and Neonatal Medicine, 29(23), 3806-3811.
dc.identifier.endpage3811
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.issue23
dc.identifier.pubmed26821682
dc.identifier.scopus2-s2.0-84961204669
dc.identifier.startpage3806
dc.identifier.urihttps://doi.org/10.3109/14767058.2016.1147551
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.3109/14767058.2016.1147551
dc.identifier.urihttp://hdl.handle.net/11452/29751
dc.identifier.volume29
dc.identifier.wos000384540600011
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherTaylor & Francis
dc.relation.journalJournal of Maternal-Fetal and Neonatal Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectObstetrics & gynecology
dc.subjectAsymmetric dimethylarginine
dc.subjectIntrauterine growth retardation
dc.subjectPerinatal care
dc.subjectPreeclampsia
dc.subjectNitric-oxide synthesis
dc.subjectPlasma-concentrations
dc.subjectEndothelial dysfunction
dc.subjectEndogenous inhibitor
dc.subjectNormal-pregnancy
dc.subjectSupplementation
dc.subjectHomocysteine
dc.subjectRestriction
dc.subjectSynthase
dc.subjectWomen
dc.subject.emtreeBiological marker
dc.subject.emtreeN(g),n(g) dimethylarginine
dc.subject.emtreeArginine
dc.subject.emtreeDimethylarginine
dc.subject.emtreeAdult
dc.subject.emtreeAmino acid blood level
dc.subject.emtreeArterial pH
dc.subject.emtreeArtery blood flow
dc.subject.emtreeArticle
dc.subject.emtreeCase control study
dc.subject.emtreeClinical article
dc.subject.emtreeControlled study
dc.subject.emtreeDiastolic blood pressure
dc.subject.emtreeFemale
dc.subject.emtreeGestational age
dc.subject.emtreeHuman
dc.subject.emtreeIntrauterine growth retardation
dc.subject.emtreeNeonatal intensive care unit
dc.subject.emtreePreeclampsia
dc.subject.emtreePregnancy outcome
dc.subject.emtreePriority journal
dc.subject.emtreePrognosis
dc.subject.emtreeProspective study
dc.subject.emtreeSystolic blood pressure
dc.subject.emtreeAnalogs and derivatives
dc.subject.emtreeBlood
dc.subject.emtreeFetal growth retardation
dc.subject.emtreeNewborn
dc.subject.emtreePreeclampsia
dc.subject.emtreePregnancy
dc.subject.emtreePregnancy outcome
dc.subject.emtreeUmbilical artery
dc.subject.emtreeUmbilical cord
dc.subject.emtreeVascularization
dc.subject.emtreeYoung adult
dc.subject.meshAdult
dc.subject.meshArginine
dc.subject.meshCase-control studies
dc.subject.meshFemale
dc.subject.meshFetal growth retardation
dc.subject.meshGestational age
dc.subject.meshHumans
dc.subject.meshInfant, newborn
dc.subject.meshPre-eclampsia
dc.subject.meshPregnancy
dc.subject.meshPregnancy outcome
dc.subject.meshProspective studies
dc.subject.meshUmbilical arteries
dc.subject.meshUmbilical cord
dc.subject.meshYoung adult
dc.subject.scopusN(G),N(G) Dimethylarginine; Arginine; Dimethylargininase
dc.subject.wosObstetrics & gynecology
dc.titlePossible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia
dc.typeArticle
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Kadın Hastalıkları ve Doğum Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: